Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.Angina, Unstable: Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.Angina, Stable: Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.Counterpulsation: A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.Coronary Angiography: Radiography of the vascular system of the heart muscle after injection of a contrast medium.Microvascular Angina: ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).Exercise Test: Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.Electrocardiography: Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.Oxyfedrine: A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).Isosorbide Dinitrate: A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.Ergonovine: An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties.Coronary Vessels: The veins and arteries of the HEART.Amino Alcohols: Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2).Adrenergic beta-Antagonists: Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Angioplasty, Balloon, Coronary: Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.Chest Pain: Pressure, burning, or numbness in the chest.Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.Physical Exertion: Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included.Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Atherectomy, Coronary: Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional (for removing focal atheromas) and rotational (for removing concentric atheromatous plaque) atherectomy devices have been used.Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.Acetanilides: Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.Myocardial Revascularization: The restoration of blood supply to the myocardium. (From Dorland, 28th ed)Double-Blind Method: A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.Cineangiography: Motion pictures of the passage of contrast medium through blood vessels.Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.Heart Rate: The number of times the HEART VENTRICLES contract per unit of time, usually per minute.Angiocardiography: Radiography of the heart and great vessels after injection of a contrast medium.Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.Coronary Artery Bypass: Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.Phonocardiography: Graphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine.Coronary Circulation: The circulation of blood through the CORONARY VESSELS of the HEART.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Nicorandil: A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.Electrocardiography, Ambulatory: Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Sympatholytics: Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.Vasodilator Agents: Drugs used to cause dilation of the blood vessels.Plaque, Atherosclerotic: Lesions formed within the walls of ARTERIES.Ludwig's Angina: Severe cellulitis of the submaxillary space with secondary involvement of the sublingual and submental space. It usually results from infection in the lower molar area or from a penetrating injury to the mouth floor. (From Dorland, 27th ed)PropiophenonesAtenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.Calcium Channel Blockers: A class of drugs that act by selective inhibition of calcium influx through cellular membranes.Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.Ultrasonography, Interventional: The use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Blood Pressure: PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.Coronary Stenosis: Narrowing or constriction of a coronary artery.C-Reactive Protein: A plasma protein that circulates in increased amounts during inflammation and after tissue damage.Spinal Cord Stimulation: Application of electric current to the spine for treatment of a variety of conditions involving innervation from the spinal cord.Placebos: Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.Propanolamines: AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.Cardiovascular Agents: Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Hemodynamics: The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.Laser Therapy: The use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue.Fibrinolysis: The natural enzymatic dissolution of FIBRIN.Troponin T: One of the three polypeptide chains that make up the TROPONIN complex. It is a cardiac-specific protein that binds to TROPOMYOSIN. It is released from damaged or injured heart muscle cells (MYOCYTES, CARDIAC). Defects in the gene encoding troponin T result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.Recurrence: The return of a sign, symptom, or disease after a remission.Severity of Illness Index: Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.Electric Stimulation Therapy: Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.Cardiac Catheterization: Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.Collateral Circulation: Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.Neopterin: A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.Exercise Tolerance: The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.Heart: The hollow, muscular organ that maintains the circulation of the blood.Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)Trimetazidine: A vasodilator used in angina of effort or ischemic heart disease.Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Diltiazem: A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.Delayed-Action Preparations: Dosage forms of a drug that act over a period of time by controlled-release processes or technology.Diagnostic Techniques, Cardiovascular: Methods and procedures for the diagnosis of diseases or dysfunction of the cardiovascular system or its organs or demonstration of their physiological processes.Prenylamine: A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1406)Indoramin: An alpha-1 adrenergic antagonist that is commonly used as an antihypertensive agent.Stents: Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.Stroke Volume: The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.Colic: A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation that is commonly seen in infants. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.Fibrinogen: Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.Pentaerythritol Tetranitrate: A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1025)Regression Analysis: Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.PropylaminesDipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)Chi-Square Distribution: A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.Vectorcardiography: Recording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time.Platelet Aggregation Inhibitors: Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.Case-Control Studies: Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.Incidence: The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.Creatine Kinase: A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Tomography, Emission-Computed, Single-Photon: A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.Multivariate Analysis: A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.Tomography, Spiral Computed: Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.Erythrocyte Aggregation: The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.Heart Ventricles: The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.Northern IrelandDrug Tolerance: Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.Echocardiography: Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.Risk Assessment: The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)Hemostasis: The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.Blood Viscosity: The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.Postcholecystectomy Syndrome: Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.

The effect of race and sex on physicians' recommendations for cardiac catheterization. (1/2517)

BACKGROUND: Epidemiologic studies have reported differences in the use of cardiovascular procedures according to the race and sex of the patient. Whether the differences stem from differences in the recommendations of physicians remains uncertain. METHODS: We developed a computerized survey instrument to assess physicians' recommendations for managing chest pain. Actors portrayed patients with particular characteristics in scripted interviews about their symptoms. A total of 720 physicians at two national meetings of organizations of primary care physicians participated in the survey. Each physician viewed a recorded interview and was given other data about a hypothetical patient. He or she then made recommendations about that patient's care. We used multivariate logistic-regression analysis to assess the effects of the race and sex of the patients on treatment recommendations, while controlling for the physicians' assessment of the probability of coronary artery disease as well as for the age of the patient, the level of coronary risk, the type of chest pain, and the results of an exercise stress test. RESULTS: The physicians' mean (+/-SD) estimates of the probability of coronary artery disease were lower for women (probability, 64.1+/-19.3 percent, vs. 69.2+/-18.2 percent for men; P<0.001), younger patients (63.8+/-19.5 percent for patients who were 55 years old, vs. 69.5+/-17.9 percent for patients who were 70 years old; P<0.001), and patients with nonanginal pain (58.3+/-19.0 percent, vs. 64.4+/-18.3 percent for patients with possible angina and 77.1+/-14.0 percent for those with definite angina; P=0.001). Logistic-regression analysis indicated that women (odds ratio, 0.60; 95 percent confidence interval, 0.4 to 0.9; P=0.02) and blacks (odds ratio, 0.60; 95 percent confidence interval, 0.4 to 0.9; P=0.02) were less likely to be referred for cardiac catheterization than men and whites, respectively. Analysis of race-sex interactions showed that black women were significantly less likely to be referred for catheterization than white men (odds ratio, 0.4; 95 percent confidence interval, 0.2 to 0.7; P=0.004). CONCLUSIONS: Our findings suggest that the race and sex of a patient independently influence how physicians manage chest pain.  (+info)

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. (2/2517)

Coagulation factor levels predict arterial thrombosis in epidemiological studies, but studies of older persons are needed. We studied 3 plasma antigenic markers of fibrinolysis, viz, plasminogen activator inhibitor-1 (PAI-1), fibrin fragment D-dimer, and plasmin-antiplasmin complex (PAP) for the prediction of arterial thrombosis in healthy elderly persons over age 65. The study was a nested case-control study in the Cardiovascular Health Study cohort of 5201 men and women >/=65 years of age who were enrolled from 1989 to 1990. Cases were 146 participants without baseline clinical vascular disease who developed myocardial infarction, angina, or coronary death during a follow-up of 2.4 years. Controls remained free of cardiovascular events and were matched 1:1 to cases with respect to sex, duration of follow-up, and baseline subclinical vascular disease status. With increasing quartile of D-dimer and PAP levels but not of PAI-1, there was an independent increased risk of myocardial infarction or coronary death, but not of angina. The relative risk for D-dimer above versus below the median value (>/=120 microg/L) was 2.5 (95% confidence interval, 1.1 to 5.9) and for PAP above the median (>/=5.25 nmol/L), 3.1 (1.3 to 7.7). Risks were independent of C-reactive protein and fibrinogen concentrations. There were no differences in risk by sex or presence of baseline subclinical disease. D-dimer and PAP, but not PAI-1, predicted future myocardial infarction in men and women over age 65. Relationships were independent of other risk factors, including inflammation markers. Results indicate a major role for these markers in identifying a high risk of arterial disease in this age group.  (+info)

Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. (3/2517)

OBJECTIVE: To assess the effectiveness of a programme to coordinate and support follow up care in general practice after a hospital diagnosis of myocardial infarction or angina. DESIGN: Randomised controlled trial; stratified random allocation of practices to intervention and control groups. SETTING: All 67 practices in Southampton and south west Hampshire, England. SUBJECTS: 597 adult patients (422 with myocardial infarction and 175 with a new diagnosis of angina) who were recruited during hospital admission or attendance at a chest pain clinic between April 1995 and September 1996. INTERVENTION: Programme to coordinate preventive care led by specialist liaison nurses which sought to improve communication between hospital and general practice and to encourage general practice nurses to provide structured follow up. MAIN OUTCOME MEASURES: Serum total cholesterol concentration, blood pressure, distance walked in 6 minutes, confirmed smoking cessation, and body mass index measured at 1 year follow up. RESULTS: Of 559 surviving patients at 1 year, 502 (90%) were followed up. There was no significant difference between the intervention and control groups in smoking (cotinine validated quit rate 19% v 20%), lipid concentrations (serum total cholesterol 5.80 v 5.93 mmol/l), blood pressure (diastolic pressure 84 v 85 mm Hg), or fitness (distance walked in 6 minutes 443 v 433 m). Body mass index was slightly lower in the intervention group (27.4 v 28.2; P=0.08). CONCLUSIONS: Although the programme was effective in promoting follow up in general practice, it did not improve health outcome. Simply coordinating and supporting existing NHS care is insufficient. Ischaemic heart disease is a chronic condition which requires the same systematic approach to secondary prevention applied in other chronic conditions such as diabetes mellitus.  (+info)

The transmyocardial laser revascularization international registry report. (4/2517)

AIMS: This report aimed to provide an analysis of the data submitted from Europe and Asia on transmyocardial laser revascularization. METHODS AND RESULTS: Prospective data was recorded on 967 patients with intractable angina not amenable to conventional revascularization in 21 European and Asian centres performing transmyocardial laser revascularization using the PLC Medical Systems CO2 laser. Patient characteristics, operative details and early complications following transmyocardial laser revascularization were recorded. The in-hospital death rate was 9.7% (95% confidence interval 7.8% to 11.6%). Other early complications were consistent with similar cardiothoracic surgical procedures. There was a decrease of two or more Canadian Cardiovascular Score angina classes in 47.3%, 45.4% and 34.0% of survivors at 3, 6 and 12 months follow-up, respectively (P=0.001 for each). Treadmill exercise time increased by 42 s at 3 months (P=0.008), 1 min 43 s at 6 months (P<0.001) and 1 min 50 s at 12 months (P<0.001) against pre-operative times of 6 min. CONCLUSION: Uncontrolled registry data suggest that transmyocardial laser revascularization may lead to a decrease in angina and improved exercise tolerance. It does, however, have a risk of peri-operative morbidity and mortality. Definitive results from randomized controlled trials are awaited.  (+info)

Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study. (5/2517)

AIMS: Determination of the influence of therapy with bisoprolol and nifedipine on the heart rate variability of patients from the Total Ischemic Burden Bisoprolol Study and examination of the prognostic value. METHODS AND RESULTS: Four hundred and twenty-two patients with stable angina were included. The heart rate variability was determined over a period of 24 h. Parameters determined: standard deviation of the mean of all corrected RR intervals, standard deviation of all 5 min mean cycle lengths, square root of the mean of the squared differences of successive corrected RR intervals. Nifedipine reduced the mean values of all heart rate variability parameters tested. Square root of the mean of the square differences of successive corrected RR intervals increased under bisoprolol. Standard deviation of the mean of all corrected RR intervals and standard deviation of all 5 min mean cycle lengths increased from low baseline values and declined from higher baseline values. The increase in heart rate variability under therapy was accompanied by a tendency towards a better prognosis. Patients with an increase in heart rate variability and simultaneous complete suppression of ischaemia under therapy displayed no serious events in the course of one year. CONCLUSIONS: The increase in the heart rate variability, which can be regarded as prognostically favourable, was predominantly observed under bisoprolol. The parameter constellation of an increase in heart rate variability and complete ischaemia suppression on the 48-h Holter ECG was associated with the greatest benefit.  (+info)

Evaluation of technician supervised treadmill exercise testing in a cardiac chest pain clinic. (6/2517)

OBJECTIVE: To determine the efficacy and safety of trained cardiac technicians independently performing treadmill exercise stress tests as part of the assessment of patients with suspected angina pectoris. DESIGN: Retrospective comparison of 250 exercise tests performed by cardiac technicians and 225 tests performed by experienced cardiology clinical assistants (general practitioners who perform regular NHS cardiology duties), and consultant cardiologists over the same time period. SETTING: Regional cardiac centre with a dedicated cardiac chest pain clinic. PATIENTS: All patients were referred by their general practitioners with a history of recent onset of chest pain, which was suspected to be angina pectoris. OUTCOME MEASURES: Peak workload achieved, symptoms, indications for termination, complications. RESULTS: The diagnostic yield of technician supervised tests (percentage positive or negative) was similar to that of medically supervised tests (76% v 69%, NS). The average peak workload achieved by patients was less by 1.2 mets (p < 0.005). This was probably due to more tests being terminated earlier due to chest pain and ST segment depression in the technician group compared with doctors (10% and 16% v 5% and 11% respectively, p = 0.06 and 0.07). One patient in the technician supervised group developed a supraventricular tachycardia during the recovery phase of the exercise test. CONCLUSIONS: Technician supervised stress testing is associated with a high diagnostic rate and low complication rate in patients with suspected ischaemic heart disease. Its efficacy is comparable to tests supervised by experienced doctors and its use should be encouraged.  (+info)

Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project. (7/2517)

OBJECTIVE: We aimed to assess the effectiveness of a nurse-led programme to ensure that follow-up care is provided in general practice after hospital diagnosis of myocardial infarction (MI) or angina pectoris. METHODS: We conducted a randomized controlled trial with stratified random allocation of practices to intervention and control groups within all 67 practices in Southampton and South-West Hampshire, England. The subjects were 422 adult patients with a MI and 175 patients with a new diagnosis of angina recruited during hospital admission or chest pain clinic attendance between April 1995 and September 1996. Intervention involved a programme of secondary preventive care led by specialist liaison nurses in which we sought to improve communication between hospital and general practice and to encourage general practice nurses to provide structured follow-up. The main outcome measures were: extent of general practice follow-up; attendance for cardiac rehabilitation; medication prescribed at hospital discharge; self-reported smoking, diet and exercise; and symptoms of chest pain and shortness of breath. Follow-ups of 90.1 % of subjects at 1 month and 80.6% at 4 months were carried out. RESULTS: Median attendance for nurse follow-up in the 4 months following diagnosis was 3 (IQR 2-5) in intervention practices and 0 (IQR 0-1) in control practices; the median number of visits to a doctor was the same in both groups. At hospital discharge, levels of prescribing of preventive medication were low in both intervention and control groups: aspirin 77 versus 74% (P = 0.32), cholesterol lowering agents 9 versus 10% (P = 0.8). Conversely, 1 month after diagnosis, the vast majority of patients in both groups reported healthy lifestyles: 90 versus 84% reported eating healthy food (P = 0.53); 73 versus 67% taking regular exercise (P = 0.13); 89 versus 92% not smoking (P = 0.77). Take up of cardiac rehabilitation was 37% in the intervention group and 22% in the control group (P = 0.001); the median number of sessions attended was also higher (5 versus 3 out of 6). CONCLUSIONS: The intervention of a liaison nurse is effective in ensuring that general practice nurses follow-up patients after hospital discharge. It does not alter the number of follow-up visits made by the patient to the doctor. Levels of prescribing and reported changes in behaviour at hospital discharge indicate that the main tasks facing practice nurses during follow-up are to help patients to sustain changes in behaviour, to encourage doctors to prescribe appropriate medication and to encourage patients to adhere to medication while returning to an active life. These are very different tasks to those traditionally undertaken by practice nurses in relation to primary prevention, where the emphasis has been on identifying risk and motivating change. Assessment of the effectiveness of practice nurses in undertaking these new tasks requires a longer follow-up.  (+info)

The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. (8/2517)

OBJECTIVES: The study aim was to determine observational differences in costs of care by the coronary disease diagnostic test modality. BACKGROUND: A number of diagnostic strategies are available with few data to compare the cost implications of the initial test choice. METHODS: We prospectively enrolled 11,372 consecutive stable angina patients who were referred for stress myocardial perfusion tomography or cardiac catheterization. Stress imaging patients were matched by their pretest clinical risk of coronary disease to a series of patients referred to cardiac catheterization. Composite 3-year costs of care were compared for two patients management strategies: 1) direct cardiac catheterization (aggressive) and 2) initial stress myocardial perfusion tomography and selective catheterization of high risk patients (conservative). Analysis of variance techniques were used to compare costs, adjusting for treatment propensity and pretest risk. RESULTS: Observational comparisons of aggressive as compared with conservative testing strategies reveal that costs of care were higher for direct cardiac catheterization in all clinical risk subsets (range: $2,878 to $4,579), as compared with stress myocardial perfusion imaging plus selective catheterization (range: $2,387 to $3,010, p < 0.0001). Coronary revascularization rates were higher for low, intermediate and high risk direct catheterization patients as compared with the initial stress perfusion imaging cohort (13% to 50%, p < 0.0001); cardiac death or myocardial infarction rates were similar (p > 0.20). CONCLUSIONS: Observational assessments reveal that stable chest pain patients who undergo a more aggressive diagnostic strategy have higher diagnostic costs and greater rates of intervention and follow-up costs. Cost differences may reflect a diminished necessity for resource consumption for patients with normal test results.  (+info)

Angina Pectoris Drugs Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. Angina pectoris is an initial presentation of coronary heart disease (CHD) and exerts a major impact on quality of life (QOL), costs to the society and ability to work.. Chronic stable angina pectoris has a prevalence of 2.0 - 4.0% in the seven major markets (U.S., U.K., Germany, France, Italy, Spain, Japan). Heart Disease and Stroke Statistics from American Heart Association estimates indicate that over nine million adults in the U.S. have chronic angina pectoris.. Get Free Sample Copy of Report ...
Angina pectoris is the medical term for chest pain caused by a lack of blood and/or oxygen in the heart muscle. The term comes from the Greek word "ankhon" meaning "strangling" and the Latin word "pectus" meaning "chest". This is most likely due to the fact that someone suffering from this condition describes the pain of an attack as a squeezing sensation, a tightness in the chest, or a feeling of pressure.. In addition to chest discomfort, pain from angina pectoris may also be felt in the upper abdomen, neck, jaw, back, or shoulders. The pain can be accompanied by sweating, breathlessness, or nausea. Angina pectoris attacks usually last for 1 to 5 minutes; pain lasting only a few seconds is normally not angina pectoris. Angina pectoris attacks that worsen as the attack progresses, angina pectoris that occurs suddenly while you are at rest, and angina pectoris lasting longer than 15 minutes are all considered signs of unstable angina. Unstable angina is an indication that an individual has a ...
The global angina pectoris drugs market is expected to be valued at USD 10.6 Billion by 2022, as per a new report by Grand View Research, Inc. The global angina pectoris market is collectively driven by demand for disease-modifying and targeted treatments, increased expenditure on healthcare and availability of effective treatment methods across the emerging markets.. (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO ) Additionally, the rising prevalence and incidence of angina pectoris is anticipated to fuel the market growth. Chronic stable angina pectoris has a prevalence of 2.0-4.0% in developed markets such as the U.S., the U.K., Germany, France, Italy, Spain and Japan. The prevalence of angina pectoris rises sharply with age in both genders, ranging from 2.0- 5.0% in men aged 45-54 to 10.0-20.0% in men aged 65-74, and from 0.1-1.0% in women aged 45-54 to 10.0-15.0% in women aged 65-74. The disease symptoms can be managed by following a healthy lifestyle.. Browse full research ...
TY - JOUR. T1 - Left Ventricular Fistula as a Cause of Intractable Angina Pectoris. T2 - Successful Surgical Repair. AU - Housman, Leland B.. AU - Morse, John. AU - Litchford, Britt. AU - Stein, Robert. AU - Mazur, John. AU - Starr, Albert. PY - 1978/7/28. Y1 - 1978/7/28. N2 - Two patients had intractable angina pectoris due to left-coronary-artery to left-ventricle fistulas. Surgical repair resulted in complete relief of symptoms. Postoperative cardiac catheterization showed obliteration of the fistulas, with preservation of ventricular function. Operative therapy is indicated in this disorder.. AB - Two patients had intractable angina pectoris due to left-coronary-artery to left-ventricle fistulas. Surgical repair resulted in complete relief of symptoms. Postoperative cardiac catheterization showed obliteration of the fistulas, with preservation of ventricular function. Operative therapy is indicated in this disorder.. UR - ...
Define angina pectoris. angina pectoris synonyms, angina pectoris pronunciation, angina pectoris translation, English dictionary definition of angina pectoris. n. Severe paroxysmal pain in the chest associated with an insufficient supply of blood to the heart. n. a sensation of crushing pressure in the chest, usu....
Purpose: Spinal cord stimulation (SCS) relieves angina pectoris in patients with ischemic heart disease, but its mechanisms of action remain incompletely understood. The goal of this study was to determine whether short-term SCS therapy improves myocardial blood flow (MBF) and myocardial flow reserve (MFR) in patients with myocardial ischemia.. Methods: The study group consisted of 18 patients (16 males) ageing 59 to 84 years who had severe stable angina pectoris (CCS class 3-4 in 70%) despite optimized medical therapy, evidence of myocardial ischemia in non-invasive testing, but not being amenable to further revascularization. All patients had three-vessel-disease and prior coronary artery bypass Surgery. Nine had prior myocardial infarction. Patients with recent MI or ejection fraction ,40% were excluded. Quantitative myocardial blood flow was measured with positron emission tomography (PET) and [15O]H2O during rest and adenosine stress before turning the SCS device on (baseline) and again ...
This double-blind, placebo-controlled trial of intramyocardial injection of autologous CD34+ stem cells in patients with intractable angina provides preliminary evidence for the safety of this approach.10 Evaluation of bioactivity reveals trends in favor of the cell-treated patient in most of the outcome measures. Together, these outcomes describe a successful first-in-human study and serve as the basis for proceeding with a larger phase IIb study, which is under way. The findings also raise many questions, most of which cannot be answered but which are nevertheless important to pose as the field of stem cell therapy continues to evolve.. Two parameters appeared worse in the placebo group at the 3-month follow-up visit: angina frequency and NTG use. At 6 months, angina frequency in the placebo-treated patients was reduced compared with baseline, whereas NTG use remained higher. In contrast, exercise tolerance, CCS class, and the Seattle Angina Questionnaire parameters of angina frequency, ...
TY - JOUR. T1 - CT attenuation features of individual calcified coronary plaque. T2 - differences among asymptomatic, stable angina pectoris, and acute coronary syndrome groups. AU - Huang, Yi-Luan. AU - Lin, Huey-Shyan. AU - Wu, Carol C. AU - Wu, Fu-Zong. AU - Yeh, Chinson. AU - Chiou, Kuan-Ran. AU - Mar, Guang-Yuan. AU - Wu, Ming-Ting. PY - 2015. Y1 - 2015. N2 - BACKGROUND: Coronary artery calcium (CAC) assessed by non-contrast cardiac CT has been shown to be an independent factor from the Framingham risk factors in predicting cardiovascular events. However, many patients with acute coronary syndrome (ACS) have low CAC score. A recent study that re-analyzed the previous CAC CT scan of MESA cohort showed that in subjects with global lower density, CAC was associated with higher risk of ACS. We aimed to further evaluate the characteristics of CAC attenuation features in ACS subjects, in comparison to asymptomatic and stable angina pectoris (SAP) groups.METHODS: In a period of 18 months, 524 ...
The term "angina pectoris" refers to chest pain. Angina is classified into three groups: 1. Stable angina (or, "effort angina"); 2. Unstable angina ("crescendo angina"); and 3. Microvascular angina ("syndrome X angina"). The 3rd type is caused by narrowing of the tiny blood vessles supplying the heart muscle and the symptoms vary, making it less easy to identify, but the good news is that its usually easy to treat and not fatal. Stable or effort angina refers to the more common type of chest pain related to myocardial ischemia (starving the heart muscle of blood and therefore, oxygen). This type is brought on by some form of activity like running or walking with slight or no symptoms noted at rest. This type responds quickly to the use of nitroglycerine under the tongue, and symptoms usually only last a few minutes after discontinuing the activity and reoccurs when activity resumes. It can continue for a long time but may never progress into unstable angina, which is then treated surgically, ...
Angina is chest pain or uneasiness that occurs when an area of your heart muscle doesnt get enough oxygen-rich blood. Angina may feel like pressure or squeeze in your chest. The pain also may occur in your shoulders, arms, neck, jaw, or back. Angina pain may even feel like indigestion.. Angina isnt a disease; its a symptom of an fundamental heart problem. Angina usually is a symptom of coronary heart disease (CHD), also called coronary artery disease.. Angina - or angina pectoris (Latin for squeezing of the chest) - is chest pain, discomfort, or tightness that occurs when an area of the heart muscle is receiving decreased blood oxygen supply.. It is not a disease itself, but rather a symptom of coronary artery disease, the most general type of heart disease. The lack of oxygen rich blood to the heart is usually a result of narrower coronary arteries due to plaque buildup, a state called atherosclerosis.. Angina is chest pain or uneasiness you get when your heart muscle does not get enough ...
The goal of the treatment of chronic stable angina is to reduce the symptoms, delay the progression of atherosclerosis, and prevent cardiovascular events. In order to achieve these goals, lifestyle modifications and medical therapy are the first line treatment. Revascularization is done to increase survival in specific conditions where the stenosis of the coronary arteries is anatomically and functionally significant and the symptoms are refractory to medical therapy. There are currently two well-established revascularization approaches for the treatment of chronic stable angina caused by coronary atherosclerosis: CABG and PCI. Since the introduction of coronary artery bypass surgery in 1967 and percutaneous transluminal coronary angioplasty (PTCA) in 1977, research has supported the effective usage of both strategies for treatment of patients with chronic stable angina. However, as with any treatment method, both methodologies have weaknesses. The choice between PCI and CABG is based upon ...
Angina pectoris. Artwork showing a heart and a human figure, with arrows (purple) showing the characteristic distribution of pain in the chest when the heart muscle does not receive enough blood. This condition is known as angina pectoris. Pain is felt in the chest radiating towards the neck, right shoulder, right side, and down the left arm. The partially sectioned left coronary artery on the heart artwork shows atheroma deposits (yellow) due to atherosclerosis. It is this blockage of the coronary arteries that reduces the blood supply and causes angina pectoris. In severe cases, it can lead to a heart attack. - Stock Image C022/6405
Get information, facts, and pictures about angina pectoris at Encyclopedia.com. Make research projects and school reports about angina pectoris easy with credible articles from our FREE, online encyclopedia and dictionary.
... According Stratistics MRC, the Global Angina Pectoris Drugs Market is - Market research report and industry analysis - 11172460
Prior to my diagnosis of stable angina pectoris I suffered daily with what I thought was simply severe chest pain and heartburn. I went to my family doctor and he diagnosed me with stable angina. The tests showed that my heart was not receiving enough blood and oxygen to meet its needs. Once I started Vastarel my angina symptoms disappeared never to come back. It is amazing.. vastarel pills purchase online shop. buy generic vastarel shopping. purchase now vastarel shop canada. where to buy indian vastarel. online trizedon store. reload strip cardaptan 30mg exactly pills. mifepristone and vastarel online. generic vastarel manufacturers. best price screams carvidon radar generic. Providing our clients with the best possible services available online we aim the steady development of our business, and that is why we work hard to enlarge our audience by stimulating seasonal sales and special offers for our regular customers.. walgreens trial pharmacy trizedon 60mg medicine angina excellent ...
182 patients (median age 63 y in the TMR group, 65 y in the medication-alone group; 91% women) who had Canadian Cardiovascular Society Angina (CCSA) scores of III or IV after maximum tolerated doses of ≥ 2 antianginal drugs, left ventricular ejection fraction ≥ 30%, reversible perfusion defects on dipyridamole thallium testing, and ≥ 1 region of protected myocardium. Exclusion criteria included myocardial infarction in the previous 3 months, severe symptomatic heart failure, history of clinically important ventricular arrhythmias or cardiac transplantation, or lack of fitness for surgery. Follow-up was 84% for change in exercise duration and 89% for change in CCSA scores ...
Angina Symptoms and what they mean Angina is caused by the narrowing of the Coronary arteries, these are the vessels that supply your heart with blood. The
{ consumer: Have angioplasty for stable angina, along with taking medicines and making healthy lifestyle changes. Take medicines and make lifestyle changes to treat stable angina. This is called medical therapy. This decision aid is for people who have coronary artery disease and stable angina. This means that your angina..., clinical: Have angioplasty for stable angina, along with taking medicines and making healthy lifestyle changes. Take medicines and make lifestyle changes to treat stable angina. This is called medical therapy. This decision aid is for people who have coronary artery disease and stable angina. This means that your angina... } Solano County, California
The angina is the medical condition in which the person faces pain in the chest, and that pain may extend towards the left arm of the person. Angina also named angina pectoris is an initial level pain that lasts for quite some time. The main reason for such pain is the inadequate supply of the blood to the heart. It wont be wrong to say that ischemia causes angina. The ischemia is the condition of the short supply of the blood and angina comes out as the result of it. Many of the expert physicians term angina pectoris as the mini heart attack as it is often perceived as the alarm of the serious heart issues. In a maximum of the cases angina is nothing more than pain, means it doesnt lead to the death of the person. Angina indicates the heart trouble at the initial level when the person may undergo the ischemia. The inadequacy of the blood leads to the issues like angina pectoris, which are not much serious if treated at initial level properly. Mainly there are two types of angina, one is ...
Juul-Möller and colleagues state that the Swedish Angina Pectoris Aspirin Trial is a study of primary prevention because documented previous MI was an exclusion criterion. All patients, however, were presumed to have coronary artery disease for an average of 4.7 years, based on "symptoms of chronic stable angina pectoris." The extent and severity of coronary artery disease is not defined. The number of patients who had coronary angiography or revascularization is also not stated, although patients already on or requiring aspirin were excluded. The intervention is more rightly considered secondary prevention because event rates were presumed and shown to be higher than in healthy persons. As such, the findings add to the already compelling body of data showing that aspirin reduces infarction, stroke, and death in patients with atherosclerotic disease. The trial is noteworthy in several respects. First, important reductions in the primary and secondary end points were seen with an aspirin dose of ...
Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy.
Editor,-I enjoyed the prospective study by Cooke et al (Gut1998;42:323-329) on the relation between oesophageal abnormalities and chest pain in patients with normal coronary angiograms and with angina pectoris. This study confirms the findings of previous studies1 2 that the oesophagus is responsible for chest pain in a high percentage of patients with coronary artery disease, and that an episode of gastro-oesophageal reflux nearly always triggers this pain.. However, no explanation for this unexpected finding has been given. The tentative proposition that it is the result of a decreased angina threshold3 and a reflex coronary ischaemia, both induced by the contact of acid with the oesophageal mucosa, is not acceptable for two reasons: firstly, because this oesophagocardiac reflex may be the basis for linked angina but not for oesophageal angina and, secondly, because the patients should have shown simultaneous electrocardiographic (ECG) abnormalities during the pain induced by the acid ...
The term angina pectoris refers to a feeling of pain or discomfort in the chest. Angina pectoris occurs when the heart muscle does not get enough blood and as a result, not enough oxygen, to function normally. Angina pectoris is usually caused by the hardening of the arteries. When plaques largely block the coronary
Is Angina Pectoris a common side effect of Valsacor? View Angina Pectoris Valsacor side effect risks. Male, 72 years of age, weighting 158.7 lb, was diagnosed with benign prostatic hyperplasia, hypertension and took Valsacor .
Angina pectoris: | | | | | Angina pectoris | | | ... World Heritage Encyclopedia, the aggregation of the largest online encyclopedias available, and the most definitive collection ever assembled.
In recent years there has been growing interest in coronary artery disease in women, particularly with regard to gender differences. We know from the Framingham study that women develop coronary disease at an older age and often have different presenting manifestations. For example, women are more likely to have chest pain as their initial symptom (1). Several studies have investigated gender differences with respect to outcome after myocardial infarction but relatively few have examined outcomes after diagnosis of angina. The study by Orencia and colleagues compares outcomes in men and women with angina pectoris. The diagnosis of angina was based on symptoms alone and did not require objective evidence of ischemia. Details regarding the character of chest pain or the frequency of typical compared with atypical pain were not provided. The finding of a more favorable prognosis in women with an initial diagnosis of angina is encouraging but may be misleading. As the authors acknowledge, angina is ...
There are three types of angina - stable, unstable and prinzmetals. Stable angina is the most common and symptoms usually last for a few minutes before they subside, often with the help of nitroglycerine tablets.. With unstable angina the symptoms can be more severe and not so predictable. The attacks often last much longer and can occur even at times of rest. An unstable attack can be a precursor to a heart attack and thus it is taken more seriously than stable angina. Medical attention should be sought immediately at the first sign of unstable angina.. Prinzmetals, is defined as angina that occurs when the patient is at rest, rather than the result of physical exercise. Dr James Pierce Ph.D., relates that hes identified the cause of this angina. He says that it generally occurs at certain times of the day, in the early morning and late afternoon.(1) These are, as it happens, the times of day when Mg is at its lowest ebb in the body.. Dr Pierce estimates that some 50% of sudden heart attacks ...
In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows down and makes it hard for oxygen-rich blood to reach the heart. This causes angina or chest pain. Those suffering from angina may experience back, neck, shoulder, arm, or jaw pain. Those with RFA have angina symptoms that are more severe and difficult to manage than those who experience regular stable angina. The symptoms are usually unmanageable; however, there are few specialized treatments that can aid in reducing the severity of the symptoms. A non-invasive therapy known as Enhanced External Counter Pulsation (EECP) places compressive cuffs on the upper and lower legs (calves, upper, and thighs). Along with ...
To demonstrate the clinical efficacy and safety of vascular endothelial growth factor(VEGF165)when delivered by direct myocardial injection through the NOGA navigational catheter to improve myocardial perfusion in patients with severe angina pectoris for whom conventional PCI or CABG are either not possible or not ideal.Secondary objective will be to determine the effects of VEGF gene therapy on angina symptoms, patient perceived quality of life and exercise ...
[82 Pages Report] Check for Discount on Chronic Stable Angina Global Clinical Trials Review, H1, 2016 report by GlobalData. Chronic Stable Angina Global Clinical Trials Review, H1, 2016 Summary...
Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa [HAALSI] Baseline Survey: Agincourt, South Africa, 2015 (ICPSR 36633 ...
Studies on patients with angina pectoris and normal coronary angiograms: with special reference to adenosine as a modulator of pain ...
Seattle Angina Questionnaire, a 19-item questionnaire that quantifies physical limitations due to angina, any recent change in the severity of angina, the frequency of angina, satisfaction with treatment, and quality of life. Scores range from 0 to 100; higher scores indicate better health status.With a score of 20 or more on the angina-frequency scale indicating that the patient was clinically significant change ...
An open, randomized, controlled, multicenter study to assess the change in time to onset of 1-mm-ST-segment depression produced by carvedilol (Dilatrend) versus metoprolol in patients with chronic stable angina pectoris ...
Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms include anxiety, increased or irregular heart rate, paleness and cold…
In this trial of patients with T2DM, established CAD, and stable angina, ranolazine was more effective than placebo in reducing the primary outcome of average weekly angina episodes, as well as average weekly sublingual nitroglycerin use. These results were consistent across the subgroups of baseline average weekly angina episodes, number of concomitant antianginal medications, age, and sex. The therapeutic benefit of ranolazine versus placebo was greater among patients enrolled outside of Russia, Ukraine, and Belarus, and among those with higher baseline HbA1c. In addition, ranolazine was safe and well tolerated in this patient population.. While patients with T2DM and CAD have more extensive disease (7,8) and worse outcomes (20,21) than those without DM, the data on whether they experience more angina are conflicting. Several older studies suggested that patients with DM have less angina than their non-DM counterparts due to an increased likelihood of "silent" ischemia related to diabetic ...
Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a metabolic modulator , ranolazine is now considered to be a late sodium current blocker . This review tries to summarize the mechanism of antianginal effects of ranolazine. ...
This study is investigating the effect of sitagliptin on the progression of coronary atherosclerosis in patients with diabetes and stable angina pectoris
Angina pectoris is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand. Angina is a common presenting symptom (typically, chest pain) among patients with coronary artery disease.
Angina pectoris, also known as Angina, a symptoms of Ischemic heart disease, is defined as a condition of chest pain caused by poor blood flow through the blood vessels due to obstruction or spasm of the coronary arteries resulting of lack of blood that lead to lack of oxygen supply and waste removal. Preventions A. …. ...
... , also known as Angina, a symptoms of Ischemic heart disease, is defined as a condition of chest pain caused by poor blood flow through the blood vessels due to obstruction or spasm of the coronary arteries resulting of lack of blood that lead to lack of oxygen supply and waste removal. Types of …. ...
Objectives. We sought to define the extent to which the therapeutic efficacy of three single-drug regimens on ambulatory ischemia paralleled efficacy on other clinical manifestations of ischemia, specifically exercise test performance and anginal symptoms.. Background. Some studies have shown that the presence and severity of ambulatory ischemia are predictive of anginal symptoms and exercise test performance, whereas other studies have not. Less is known about effects of antianginal treatment and whether response to therapy for one clinical manifestation reflects therapeutic responses for other clinical manifestations.. Methods. We studied 50 patients in the Angina and Silent Ischemia Study who had documented coronary disease, an exercise test positive for ischemia, the presence of ambulatory and asymptomatic ischemia on ambulatory electrocardiographic (ECG) Holter monitoring and stable anginal symptoms. Patients received maximally tolerated dose of sustained release propranolol (mean 293 ...
... - or simply angina - is chest pain or discomfort that keeps coming back. It happens when some part of your heart does not get enough blood and oxygen.
Angina pectoris,Types as stable,unstable and even Microvascular,Signs and Symptoms,Risk factors,Diagnosis,Life Style Modification and Prinzmetal Angina
Angina is the medical term used to describe the sharp, crushing pain that one experiences when there is a limited supply of blood to the heart causing the latter to be deprived of much needed oxygen. In most cases, the angina can be felt in the chest and can radiate towards the limbs. Most medical professionals do not treat angina as a disease on its own. Instead, it is seen as a sign or a symptom of an even more serious heart condition such as Coronary Heart Disease, or what most people refer to as CHD. In a CHD, there is a build up of plaque along the walls of the arteries. This causes narrowing of the path where the oxygen-rich blood can pass through.. Although most people see angina as only one kind, there is actually four major types of angina that a person might suffer from. Of these four, it is the stable angina that is considered to be the most common. In a stable angina, the onset is pretty much predictable. For one, a stable angina typically takes place only after too much physical ...
Cardiosurgery: Angina pectoris (heart attack) | Сardiac catheterization and coronary bypass surgery (cabg). Treatment in Germany ✈ Find the best medical programs at BookingHealth - ✔Get fast quotes ✔Compare the prices ✔Online booking.
Cardiosurgery: Angina pectoris (heart attack) | Coronary bypass surgery (cabg) . Treatment in Switzerland ✈ Find the best medical programs at BookingHealth - ✔Get fast quotes ✔Compare the prices ✔Online booking.
Study Flashcards On Angina Pectoris: Pharmacology at Cram.com. Quickly memorize the terms, phrases and much more. Cram.com makes it easy to get the grade you want!
Background Coronary Heart Disease (CHD) is a disease caused by a state of imbalance between myocardial oxygen delivery and oxygen demand which is often caused by obstruction of coronary atherosclerotic disease is the underlying cause of the occurrence of CHD. Measuring the thickness of the tunica intima-media (IMT) in the common carotid artery (CCA) is considered a useful indicator of carotid atherosclerosis. Prospective study showed that the ACC is a predictor of CIMT measurements against cardio vascular events. Its debatable whether increased CIMT ACC associated with the severity of coronary artery stenosis proven by angiography examination. Objective : To determine whether increased CIMT ACC associated with the severity of coronary artery stenosis in patients with stable angina pectoris. Materials and Methods: Observational study with cross-sectional measurement methods. Subjects with stable angina pectoris, CIMT measurements right and left ACC and laboratory examination of blood and ...
An episode of angina does not indicate that a heart attack is occurring, or that a heart attack is about to occur. Angina does indicate, however, that coronary heart disease is present and that some part of the heart is not receiving an adequate blood supply. Persons with angina have an increased risk of heart attack.. A person who has angina should note the patterns of his or her symptoms--what causes the chest pain, what it feels like, how long episodes usually last, and whether medication relieves the pain. Call for medical assistance if the angina episode symptoms change sharply.. ...
Angina pectoris". Am. J. Pathol. 97 (3): 530. PMC 2042409 . PMID 389065. Prichard, R (December 1979). "Selected items from the ...
By 1907 Mackenzie experienced frequent episodes of angina pectoris which he mentioned to Sir Thomas Lewis and in 1908 he had a ... Mackenzie, James (1923). Angina pectoris. London: Henry Frowde, Hodder & Stoughton. Mackenzie, James (1908). Diseases of the ... His angina continued after 1908 and became progressively worse until in January 1925 he had a prolonged and severe attack of ... angina and died at around 4am in the morning of 26 January 1925. Before his death Mackenzie has asked that his friend John ...
Kounis syndrome (allergic angina and allergic myocardial infarction). Angina Pectoris. Etiology, Pathogenesis and Treatment. ... "Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm?" Kounis NG. International Journal of ... Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm? International Journal of Cardiology ... It was during this period when he treated two patients who developed angina progressing to acute myocardial infarction ...
Early Detection: Arrhythmia; Ischemia; Angina pectoris; Cardiac microvascular diseases Direct diagnosis of heart function after ...
Frederick Fillmore French, 52, Manhattan builder (Tudor City, Knickerbocker Village); of angina pectoris; in Pawling, N. Y. An ...
This may lead to angina pectoris (chest pain or tightness on exertion) or heart attacks. Less commonly, arteries of the brain ... Müller C (1938). "Xanthoma, hypercholesterolemia, angina pectoris". Acta Med Scandinav. 95 Suppl (89): 75-84. doi:10.1111/j. ...
He died of angina pectoris. He is known today for the "Arndt-Schulz rule", a pharmacologic principle of homeopathy that is ...
Class III/IV angina pectoris. Left main or multi vessel coronary artery disease. Need for open heart surgery within 30 days. ...
Hickie JB (August 1970). "Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial". Med. J. Aust. 2 (6): 268- ... used in the treatment of angina pectoris. It is no longer marketed by AstraZeneca, but may still be available from other ...
Unstable angina pectoris benefits from counterpulsation. Post cardiothoracic surgery-most common and useful is counterpulsation ... Preoperative use is suggested for high-risk patients such as those with unstable angina with stenosis greater than 70% of main ...
A variant form of angina pectoris. Preliminary report. Am Heart J 1959; 27:375. Grattan-Guinness, Ivor (1997): The Rainbow of ... Prinzmetal angina: also known as variant angina, referring to angina (chest pain) caused by vasospasm of the coronary arteries ... Electrocardiographic study during a paroxysm of angina pectoris. Am Heart J 1933; 9:259. Prinzmetal, M, Kennamer, R, Merliss, R ... Electrocardiographic changes during brief attacks of angina pectoris. Lancet 1931; 1:15. Brow, GR, Holman, DV. ...
Sandler, G. (1961). "Clinical Evaluation of Propatylnitrate in Angina Pectoris". British Medical Journal. 2 (5269): 1741-1744. ...
Thomas Jones died in 1803; the cause of death was angina pectoris. He was buried at the family chapel at Caebach, Llandrindod ...
It was also used in the treatment of angina pectoris and schizophrenia. Pheniprazine has been largely discontinued due to ... Sandler, G (1961). "Clinical evaluation of pheniprazine in angina pectoris". British medical journal. 1 (5228): 792-4. doi: ...
Cardiac chest pain is called angina pectoris. Some causes of noncardiac chest pain include gastrointestinal, musculoskeletal, ... Prinzmetal's angina - Chest pain is caused by coronary vasospasm. More common in women younger than 50 years. Patient usually ... Acute coronary syndrome Stable or unstable angina Myocardial infarction ("heart attack") - People usually complained of a ...
... has been used to relieve the pain associated with angina pectoris by acting as a selective coronary vasodilator. This ... Osher, Harold; Katz, Kermit; Wagner, Donald (1951). "Khellin in the treatment of angina pectoris". The New England Journal of ... Conn, James J. (1952). "The treatment of angina pectoris with khellin". Annals of Internal Medicine. 36 (5): 1173-1178. doi: ...
He died of angina pectoris in 1885. "Death of Ex-Mayor Socrates Tuttle". Paterson Daily Press. February 13, 1885. Retrieved ...
"Description of Angina Pectoris by William Heberden". Retrieved 29 July 2016. Bright, Richard (1831). Reports of Medical Cases, ...
"Enhanced external counterpulsation for chronic angina pectoris". The Cochrane Database of Systematic Reviews (2): CD007219. doi ... Other reviews found tentative benefit in those with angina that does not improve with medications. For stroke due to lack of ... External counterpulsation therapy (ECP) is a procedure that may be performed on individuals with angina, heart failure, or ... Some reviews did not find sufficient evidence that it was useful for either angina or heart failure. ...
Duff died in May 1922 from angina pectoris. 1882 Michigan Wolverines football team 1884 Michigan Wolverines football team "1882 ...
The official cause of death was Angina pectoris. "J. A Maynard for Surveyor". The Boston Daily Globe. October 19, 1913. " ...
Leighton died the next day of angina pectoris. Leighton remained a bachelor and rumours of his having an illegitimate child ...
1966). "The prophylactic value of propranolol in angina pectoris". Am J Cardiol. 18 (3): 370-83. doi:10.1016/0002-9149(66)90056 ... propranalol's effectiveness in headache treatment was a chance finding in patients receiving the drug for angina (chest pain ...
Murrell, William (1879). "Nitro-glycerine as a remedy for angina pectoris". The Lancet: 80-81, 113-115, 151-152, 225-227. doi: ... GTN is useful in decreasing angina attacks, perhaps more so than reversing angina once started, by supplementing blood ... William Murrell experimented with the use of nitroglycerin to alleviate angina pectoris and reduce blood pressure, and showed ... GTN is also used in the treatment of anal fissures, though usually at a much lower concentration than that used for angina ...
Murrell's administration of nitroglycerin to patients with angina pectoris was documented in the article "Nitro-glycerine as a ... Murrell, W. (1879). "NITRO-GLYCERINE AS A REMEDY FOR ANGINA PECTORIS" (PDF). The Lancet. 113 (2894): 225-227. doi:10.1016/S0140 ... for the management of patients with angina pectoris. Murrell was born in London in 1853, the son of a lawyer. He was educated ... remedy for angina pectoris," published in 1879. The article describes a case series of patients which benefited from the ...
This may lead to angina pectoris (chest pain or tightness on exertion) or heart attacks. Less commonly, arteries of the brain ... Müller C (1938). "Xanthoma, hypercholesterolemia, angina pectoris". Acta Med Scandinav. 95 Suppl (89): 75-84. doi:10.1111/j. ...
ANGINA PECTORIS. Br Med J 1906; 1 doi: https://doi.org/10.1136/bmj.1.2357.535-a (Published 03 March 1906) Cite this as: Br Med ...
... angina pectoris (nl); angina (pt); Angina pectoris (de); Angina pectoris (sk); Angina pectoris (hu); Stenokardija (lt); angina ... Angina (sl); Krūtinės angina (lt); Angina pectoris (la); Angina pectoris (ml); Angina pectoris (th); hjartekrampe, angina (nn ... Angina pectoris (af); ангина пекторис (sr); 心绞痛 (zh-sg); angina pectoris (nn); angina pectoris (nb); Stenokardiya (az); angina ... Angina pectoris (fi); மார்பு நெரிப்பு (ta); Angina pectoris (it); angina (sco); 心绞痛 (zh-hans); angina de pit (ca); 心絞痛 (zh-tw ...
Treatment of angina pectoris.. Br Med J 1969; 2 doi: https://doi.org/10.1136/bmj.2.5657.634-a (Published 07 June 1969) Cite ...
Angina is a common presenting symptom (typically, chest pain) among patients with coronary artery disease. ... Angina pectoris is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand. ... encoded search term (Angina%20Pectoris) and Angina Pectoris What to Read Next on Medscape. Medscape Consult. ... Angina Pectoris Differential Diagnoses. Updated: Dec 14, 2017 * Author: Jamshid Alaeddini, MD, FACC, FHRS; Chief Editor: Eric H ...
... , Angina, Myocardial Ischemia, Ischemic Heart Disease, Stable Angina. ... angina pectoris, Angina syndrome, Angina of effort, Angina NOS, Angina Pectoris [Disease/Finding], pectoris angina, Pain;angina ... Stable Angina Pectori, Stable Anginas, Angina Pectoris, Stable, Angina Pectori, Stable, Pectoris, Stable Angina, Angina, ... stabiele angina pectoris German. stabile Angina pectoris, Chronische stabile Angina, Angina, stabile, Angina pectoris, stabile ...
Angina is a common presenting symptom (typically, chest pain) among patients with coronary artery disease. ... Angina pectoris is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand. ... Angina Pectoris) and Angina Pectoris What to Read Next on Medscape. Related Conditions and Diseases. * Angina Pectoris ... Angina decubitus. Angina decubitus is a variant of angina pectoris that occurs at night while the patient is recumbent. Some ...
angina pectoris synonyms, angina pectoris pronunciation, angina pectoris translation, English dictionary definition of angina ... pectoris. n. Severe paroxysmal pain in the chest associated with an insufficient supply of blood to the heart. n. a sensation ... Angina pectoris - definition of angina pectoris by The Free Dictionary https://www.thefreedictionary.com/angina+pectoris ... New Latin : Latin angina, quinsy + pectoris, genitive of pectus, chest.]. angi′na pec′to•ris. (ˈpɛk tə rɪs) n. a sensation of ...
Make research projects and school reports about angina pectoris easy with credible articles from our FREE, online encyclopedia ... and pictures about angina pectoris at Encyclopedia.com. ... angina of effort and variant angina.. Angina of effort Angina ... angina †quinsy XVI; short for angina pectoris XVIII. - L. angina quinsy - Gr. agkhónē strangling, with assim. to angere (see ... angina of effort and variant angina.. Angina of effort. Angina of effort is a common disorder caused by the narrowing of the ...
Angina Pectoris. Angina, Stable. Chest Pain. Pain. Neurologic Manifestations. Nervous System Diseases. Myocardial Ischemia. ... Capadenoson in Angina Pectoris. This study has been withdrawn prior to enrollment. ... Stable angina of mild-moderate intensity (Canadian class II-III) with anti-anginal medication not changed for the last 5 weeks ... Chronic Stable Angina Drug: Capadenoson (BAY 68-4986) Drug: Placebo Phase 2 ...
Overview of Angina Pectoris. Related Tests: CK-MB, AST, Troponin. Chest pain; usually a symptom of myocardial ischemia. Types: ... Angina Pectoris is a term for chest pain caused by the heart not getting enough oxygen. This lack of oxygen is also called ... Variant angina (Prinzmetals angina) almost always occurs during periods of rest - usually at night. The cause is a spasm of a ... There are three main types of angina:. *Stable angina is characterised by predictable periods of discomfort that occur during ...
Stable angina Unstable angina (acute coronary syndrome) Cardiac syndrome X (microvascular angina) Decubitus angina Vasospastic ... 1. ANGINA PECTORIS Episodes of chest pain caused by myocardial ischaemia secondary to CAD Severity and prognosis : degree of ... INDEX 1. Angina Pectoris 2. Myocardial Infarction 3. Congestive Heart Failure 4. Hypertensive 5. Rheumatic Fever 6. Infective ... angina at rest or sudden onset with rapid increase in severity : clinical features of angina but normal coronary arteries on ...
Reversible Cardiac Failure During Angina Pectoris. Hemodynamic Effects of Atrial Pacing in Coronary Artery Disease. JOHN O. ... The normal subjects and the patients with coronary artery disease who did not experience angina during pacing reacted similarly ... The average left ventricular end-diastolic pressure during pacing in the 21 patients who developed angina was similar to ...
Reviews and ratings for adalat when used in the treatment of angina pectoris prophylaxis. Share your experience with this ... Angina Pectoris Prophylaxis aspirin, metoprolol, diltiazem, atenolol, nitroglycerin, Nitrostat, isosorbide mononitrate, ... Reviews for Adalat to treat Angina Pectoris Prophylaxis. No reviews have yet been submitted. Be the first to review this drug. ...
The Dangers of Angina Pectoris 3 Introduction 4 The Human Heart 5 Symptoms of Coronary Heart Disease 5 Heart Attack 5 Sudden ... More about Essay on The Dangers of Angina Pectoris. *. The Continuing Dilemma Of Angina Pectoris. 1657 Words , 7 Pages ... The Continuing Dilemma Of Angina Pectoris. 1657 Words , 7 Pages. The continuing dilemma of angina pectoris. Look beyond the ... The doctor used the term "angina pectoris"" (4). Angina pectoris originates from a lack of blood entering the blood vessels ...
Angina.html?id=ZwL2JXsXSH4C&utm_source=gb-gplus-shareBeta-Blockers in Hypertension and Angina Pectoris. ... acute hospitalization adrenergic alpha alpha-blocker alpha-receptors anesthesia angina pectoris Angiology atenolol beta-1- ... Beta-Blockers in Hypertension and Angina Pectoris: Different Compounds .... Ton J eophas. No preview available - 1995. ... Beta-Blockers in Hypertension and Angina Pectoris: Different Compounds .... Ton J eophas. No preview available - 2011. ...
Angina pectoris. The clinical manifestations of angina pectoris are typically provoked through exercise and abate during rest. ... CHARACTERISTICS OF PATIENTS WITH (CHRONIC REFRACTORY) ANGINA PECTORIS. Patients with chronic refractory angina lead severely ... Rosen SD, Paulescu E, Frith CD, et al. Central nervous pathways mediating angina pectoris. Lancet1994;344:147-50.. ▸ The first ... Angina pectoris is not a very specific indicator for occlusive coronary disease, since it is a relatively late, inconsistent, ...
A 60-year-old female presented with a two-year history of exertional chest pain and progressive dyspnea. Resection of a cardiac hemangioma arising from the area of the bifurcation of the left anterior descending and circumflex coronary arteries resul
Learn more about Understanding Angina Pectoris at St. Davids HealthCare movietranscript function replaceEmbed(anmationName... ... When your heart isnt getting enough oxygen you may experience chest pain or discomfort called angina pectoris. Angina (an-gin- ... A sudden change in the pattern of your angina or angina which occurs without any cause or trigger could signal unstable angina ... When you have angina, you may notice that certain activities trigger your angina symptoms. Recognizing triggers and symptoms is ...
1994) Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris. J Am Coll Cardiol 23:1592-1597, ... 1993) Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ 307:477- ... 1998) Spinal cord stimulation in intractable angina pectoris: A randomized, controlled efficacy study. Am Heart J 136:1114-1120 ... 1985) The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation 71:308- ...
Reviews and ratings for taztia xt when used in the treatment of angina pectoris prophylaxis. Share your experience with this ... Reviews for Taztia XT to treat Angina Pectoris Prophylaxis. No reviews have yet been submitted. Be the first to review this ...
The Canadian Cardiovascular Society grading of angina pectoris (sometimes referred to as the CCS Angina Grading Scale or the ... The CCS grading system for angina is a clinical tool used by doctors to assess the degree of severity of a patients angina. ... Whilst there are no defined therapy guidelines specific for each class, once the severity of the angina has been assessed, ... CCS Functional Classification of Angina) is a classification system used to grade the severity of exertional angina. ...
The diagnosis of angina is largely based on symptoms, but a substantial minority of patients diagnosed with non-cardiac chest ... Performing stable angina pectoris: an ethnographic study Soc Sci Med. 2008 Apr;66(7):1497-508. doi: 10.1016/j.socscimed.2007.12 ... The diagnosis of angina is largely based on symptoms, but a substantial minority of patients diagnosed with "non-cardiac" chest ...
... Conditions We Treat. Angina pectoris (or simply angina) is recurring chest pain or discomfort that happens ... Treatment of angina pectoris. Specific treatment for angina pectoris will be determined by the doctor based on:. * Your age, ... What are the symptoms of angina pectoris?. Angina pectoris occurs when the heart muscle (myocardium) does not receive an ... Angina pectoris and heart attack risk. An episode of angina does not indicate that a heart attack is occurring, or that a heart ...
Neurostimulation to Treat Refractory Angina Pectoris Pain (STARTSTIM). The safety and scientific validity of this study is the ... Angina Pectoris. Chest Pain. Pain. Neurologic Manifestations. Nervous System Diseases. Myocardial Ischemia. Heart Diseases. ... stable angina pectoris associated with reversible myocardial ischemia and significant coronary artery disease (CAD) ... The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris ...
Angina Pectoris, Hypercholesterolemia, Familial Hypercholesterolemia Cancer trial. Review trial description, criteria and ...
  • A ngina pectoris, or simply angina, is a coronary syndrome characterized by an oppressive substernal pain (pain under breastbone) or pressure brought on by exertion and relieved by rest that results from failure of coronary arteries to deliver adequate oxygen to heart tissue due to ischemic heart disease. (glutenfreeworks.com)
  • The most frequent cause of angina is Ischemic heart disease. (smashwords.com)
  • Angina Pectoris is an early warning symptom of an ischemic heart disease (IHD). (smashwords.com)
  • not only do 10.2 million americans have this condition and approximately 500,000 new cases of angina occur each year, but ischemic heart disease is the leading cause of death in the united states. (jaoa.org)
  • Angina pectoris is the most common type of ischemic heart disease. (healthhype.com)
  • In 2018, there were 1,128,150 diagnosed incident cases of angina pectoris in men and women combined, age 18 years and older, in the 7MM. (researchandmarkets.com)
  • The diagnosed prevalent cases of angina pectoris is expected to increase from 19.58 million cases in 2018 to 22.79 million cases in 2028, at an annual growth rate (AGR) of 1.64% across the seven major markets 7MM*, according to GlobalData, a leading data and analytics company. (globaldata.com)
  • In 1991, Kounis and Zavras described "the coincidental occurrence of chest pain and allergic reactions accompanied by clinical and laboratory findings of classical angina pectoris caused by inflammatory mediators released during the allergic insult" (1). (thefreedictionary.com)
  • The Company recently initiated the Phase 3 AWARE clinical study (Angiogenesis in Women with Angina pectoris who are not candidates for Revascularization). (thefreedictionary.com)
  • The CCS grading system for angina is a clinical tool used by doctors to assess the degree of severity of a patient's angina. (wikipedia.org)
  • Although systematic reviews of acupuncture for stable angina pectoris have been conducted previously, this study will update the evidence base by including many clinical trials that have been published in the past 5 years. (bmj.com)
  • While William Heberden gave us an excellent clinical description of angina pectoris more than 200 years ago, the understanding and management of this disorder have undergone major development since then, and especially so in recent years. (springer.com)
  • Newswise - MONTREAL June 9, 2015 - Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition. (newswise.com)
  • Stable Angina Pectoris: What Does the Current Clinical Evidence Tell Us? (jaoa.org)
  • The diagnosis of angina is primarily clinical. (healthhype.com)
  • Various nitrates are available for clinical use in angina. (healthhype.com)
  • According to MD News , a clinical news magazine for physicians, there are approximately 500,000 new cases of angina pectoris diagnosed each year . (marijuanadoctors.com)
  • The purpose of the present study was to investigate the long-term prognostic importance of selected hemostatic variables, including markers of coagulation activation, in patients with angina pectoris following initial clinical assessment and coronary angiography. (ahajournals.org)
  • To determine the effect of female gender on long-term survival and subsequent coronary heart disease events in patients with the first clinical manifestations of angina pectoris. (acpjc.org)
  • While you can't avoid all physical activities for the rest of your life in hopes of preventing these types of attacks, you can take precautions, especially if you're at an elevated risk of developing angina pectoris. (marijuanadoctors.com)
  • The publisher's epidemiologists forecast an increase in the diagnosed incident cases of angina pectoris to 1,292,695 cases in 2028 in the 7MM at an Annual Growth Rate (AGR) of 1.46% during the forecast period. (researchandmarkets.com)
  • The diagnosed prevalent cases of angina pectoris will increase to 22,797,390 cases in 2028 at an AGR of 1.64% during the forecast period. (researchandmarkets.com)
  • The comorbidities-diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and chronic renal disease-among the diagnosed incident cases and diagnosed prevalent cases of angina pectoris are also provided. (researchandmarkets.com)
  • Lastly, the report includes diagnosed prevalent cases of refractory angina among diagnosed prevalent cases of angina pectoris. (researchandmarkets.com)
  • Some people indicate the pain from angina pectoris is difficult to locate or specifically identify. (marijuanadoctors.com)
  • Ginkgo Leaf Extract and Dipyridamole Injection as Adjuvant Treatment for Angina Pectoris: A Meta-Analysis of 41 Randomized Controlled Trials. (bioportfolio.com)
  • Despite the wealth of treatments available for the management of angina pectoris, a significant proportion of patients remain refractory. (bmj.com)
  • Further major advances in the medical management of angina pectoris now depend on our ability to improve prognosis and retard the development of the atherosclerotic process. (springer.com)
  • It is effective in the management of hypertension and angina pectoris. (bioportfolio.com)
  • Hitherto, different classes of beta-blockers have been considered to be equally effective in the treatment of such conditions, but Beta-Blockers in Hypertension and Angina Pectoris provides evidence that this is not the case. (valorebooks.com)
  • Of particular interest to general practitioners.Cleophas, Ton M. is the author of 'Beta-Blockers in Hypertension and Angina Pectoris Different Compounds, Different Strategies' with ISBN 9780792335160 and ISBN 0792335163. (valorebooks.com)
  • An episode of angina is not an actual heart attack , but rather pain that results when the heart muscle temporarily receives too little blood. (encyclopedia.com)
  • Emotional stress, extreme temperatures, heavy meals, cigarette smoking , and alcohol can also cause or contribute to an episode of angina. (encyclopedia.com)
  • How long does an episode of angina last? (stdavids.com)